Clinical features, outcomes, and HLA risk factors associated with nitrofurantoin-induced liver injury

This publication has 24 references indexed in Scilit:

• HIBAG—HLA genotype imputation with attribute bagging
  The Pharmacogenomics Journal, 2013
• Susceptibility to Amoxicillin-Clavulanate-Induced Liver Injury Is Influenced by Multiple HLA Class I and II Alleles
  Gastroenterology, 2011
• Drug-Induced Acute Liver Failure
  Hepatology, 2010
• HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin
  Nature Genetics, 2009
• Causes, Clinical Features, and Outcomes From a Prospective Study of Drug-Induced Liver Injury in the United States
  Gastroenterology, 2008
• Principal components analysis corrects for stratification in genome-wide association studies
  Nature Genetics, 2006
• Drug‐induced hepatic injury: an analysis of 1100 cases reported to The Danish Committee on Adverse Drug Reactions between 1978 and 1987
  Journal of Internal Medicine, 1992
• Hepatic injury associated with the use of nitrofurans: A clinicopathological study of 52 reported cases
  Hepatology, 1988
• Adverse reactions to nitrofurantoin
  The American Journal of Medicine, 1980
• Nitrofurantoin: Another cause of drug-induced chronic active hepatitis?
  The American Journal of Medicine, 1979